Empowering Biomedical Discovery with AI Agents
Shanghua Gao, Ada Fang, Yepeng Huang, Valentina Giunchiglia, Ayush Noori, Jonathan Richard Schwarz, Yasha Ektefaie, Jovana Kondic, Marinka Zitnik
TL;DR
The paper envisions biomedical AI agents as collaborative, skeptical researchers—composed of LLMs, ML tools, experimental platforms, and human input—to accelerate discovery by decomposing complex problems into subtasks and continually updating knowledge. It presents a compound AI framework with perception, memory, interaction, and reasoning modules, and a taxonomy of multi-agent collaboration schemes and autonomy levels (0–3) across genetics, cell biology, and chemical biology. It discusses practical challenges—robustness, uncertainty, evaluation, data governance, and safety—alongside a roadmap for building capable agents, including governance and responsible deployment. The work highlights potential impacts such as virtual cell simulations, programmable phenotypic control, cellular circuit design, and novel therapies, while emphasizing the need for data availability, standardization, and ethical guidelines. Overall, it lays out a structured vision for integrating diverse AI capabilities into biomedical discovery to enhance efficiency, scale, and creativity with careful oversight.
Abstract
We envision "AI scientists" as systems capable of skeptical learning and reasoning that empower biomedical research through collaborative agents that integrate AI models and biomedical tools with experimental platforms. Rather than taking humans out of the discovery process, biomedical AI agents combine human creativity and expertise with AI's ability to analyze large datasets, navigate hypothesis spaces, and execute repetitive tasks. AI agents are poised to be proficient in various tasks, planning discovery workflows and performing self-assessment to identify and mitigate gaps in their knowledge. These agents use large language models and generative models to feature structured memory for continual learning and use machine learning tools to incorporate scientific knowledge, biological principles, and theories. AI agents can impact areas ranging from virtual cell simulation, programmable control of phenotypes, and the design of cellular circuits to developing new therapies.
